Andrew Greenstein is the Senior Research Scientist & Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9) at Gilead Sciences based in San Francisco, California, United States.
Andrew Greenstein
Senior Research Scientist & Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9) at Gilead Sciences in San Francisco, California, United States
Verified profile
a***@gilead.com
Job Title
Senior Research Scientist & Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9)
Company
Gilead Sciences
Location
San Francisco, California, United States
Seniority
Senior
Work Email
a***@gilead.com
Sign up free to see results
Colleagues at Gilead Sciences
Other verified contacts at Gilead Sciences.
Padraig ClancySenior Director Finance at Gilead SciencesMari SmokeHIV Therapeutic Specialist at Gilead SciencesSophia ChuangRevenue Accounting Manager at Gilead SciencesMichelle WongSr. Clinical Trials Manager at Gilead SciencesWinnie ChenClinical Trial Management Associate at Gilead SciencesLee SperandieuAdministrative coordinator, Medical department at Gilead SciencesSuzanne BessetteManager at Gilead SciencesJames ChrismanClinical Trial Management Associate at Gilead Sciences
Other people named Andrew Greenstein
Different professionals who share this name.
Andrew GreensteinInventory Control Associate at Island NaturalAndrew GreensteinDealer Franchising Specialist at Audi at AmericaAndrew GreensteinCo-founder At Seekeasy at SeekeasyAndrew GreensteinSenior Manager, Retail Planning Champion North America at Hanesbrands IncAndrew GreensteinCEO and Head of Production at Sf Appworks
Frequently asked
What is Andrew Greenstein's email address?
Andrew Greenstein's work email follows the pattern a***@gilead.com. Reveal it free.
What does Andrew Greenstein do?
Andrew Greenstein is the Senior Research Scientist & Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9) at Gilead Sciences.
Where is Andrew Greenstein based?
San Francisco, California, United States.
Who is the Senior Research Scientist & Leader of Research Team for Andecaliximab (ADX, GS-5745, anti-MMP9) at Gilead Sciences?
Andrew Greenstein.
Get Andrew Greenstein's verified contact details
Reveal the full work email and more. Free to start.
Try ScraperCity Free →